Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Meriva for Treatment-induced Inflammation and Fatigue in Women With Breast Cancer

NCT01740323 is registered in ClinicalTrials.gov with Andrew H Miller as lead sponsor.

NCT NCT01740323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01740323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Meriva for Treatment-induced Inflammation and Fatigue in Women With Breast Cancer
Lead sponsor
Andrew H Miller
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2015
Completion date
July 27, 2018
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer